Filed before 2025Filed 17 July 2023
Kinaset Therapeutics, Inc. has sold $28.5M so far
Kinaset Therapeutics, Inc., a pharmaceuticals company based in Medfield, MA, has sold $28.5M so far in its equity round, according to a filing dated 17 July 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 17 July 2023
- First filed
- 18 July 2022
- Round
- Equity round (amended filing)
- Amount sold
- $28.5M
- Offering size
- $41M
- Investors so far
- 3
- Based in
- Medfield, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 85% of the 1,396 tracked raises with an amount filed in 2023.
Kinaset Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Jul 2023 | Amended filing | $28.5M | This raise |
| 18 Jul 2022 | New filing | $28.5M | This raise |
| 17 Aug 2020 | New filing | $1.5M | Another raise |
More with Atlas on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.